Literature DB >> 19010996

Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections.

W C Webley1, Y Tilahun, K Lay, K Patel, E S Stuart, C Andrzejewski, P S Salva.   

Abstract

An emerging body of evidence suggests that half of asthma in both children and adults is associated with chronic lung infection. The aim of the present study was to determine the frequency of viable Chlamydia pneumoniae (Cp) and C. trachomatis (Ct) in the respiratory tracts of paediatric patients with chronic respiratory diseases. Bronchoalveolar lavage fluid (BALF) samples obtained from 182 children undergoing bronchoscopy for clinical reasons were assayed using PCR analysis, in vitro tissue culture and immunofluorescence staining for the presence of Cp and Ct. Chlamydia-specific DNA was detected by PCR in 124 (68%) out of 182 patients; 79 were positive for Cp, 77 positive for Ct and 32 for both organisms; 75 patients had cultivable Chlamydia. Ct DNA prevalence decreased, whereas Cp positivity generally increased with age. A total of 59 out of 128 asthma patients and 16 out of 54 nonasthmatics were Chlamydia culture positive. When the patients were divided into inflammatory versus noninflammatory airway disease, there were 69 (46%) out of 150 and six (18%) out of 32 BALF samples with cultivable Chlamydia, respectively. Viable Chlamydia pneumoniae and Chlamydia trachomatis occur frequently in children with chronic respiratory diseases and may be more prevalent in asthma patients. To the current authors' knowledge, this is the first report of viable Chlamydia trachomatis in the lungs of children.

Entities:  

Mesh:

Year:  2008        PMID: 19010996     DOI: 10.1183/09031936.00019508

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

Review 1.  Neonatal immunology: responses to pathogenic microorganisms and epigenetics reveal an "immunodiverse" developmental state.

Authors:  Becky Adkins
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

2.  Influence of different delivery modes on the clinical characteristics of Chlamydia trachomatis pneumonia.

Authors:  Jiejing Xu; Lili Yu; Baidi Fu; Deyu Zhao; Feng Liu
Journal:  Eur J Pediatr       Date:  2018-05-31       Impact factor: 3.183

3.  Clinical evaluation of a new single-tube multiplex reverse transcription PCR assay for simultaneous detection of 11 respiratory viruses, Mycoplasma pneumoniae and Chlamydia in hospitalized children with acute respiratory infections.

Authors:  Meng-Chuan Zhao; Gui-Xia Li; Dan Zhang; Hang-Yu Zhou; Hao Wang; Shuo Yang; Le Wang; Zhi-Shan Feng; Xue-Jun Ma
Journal:  Diagn Microbiol Infect Dis       Date:  2017-03-22       Impact factor: 2.803

Review 4.  Infection-related asthma.

Authors:  Jared I Darveaux; Robert F Lemanske
Journal:  J Allergy Clin Immunol Pract       Date:  2014-11-06

5.  Tumor necrosis factor-related apoptosis-inducing ligand translates neonatal respiratory infection into chronic lung disease.

Authors:  M R Starkey; D H Nguyen; A T Essilfie; R Y Kim; L M Hatchwell; A M Collison; H Yagita; P S Foster; J C Horvat; J Mattes; P M Hansbro
Journal:  Mucosal Immunol       Date:  2013-09-18       Impact factor: 7.313

Review 6.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

7.  The prevalence and identity of Chlamydia-specific IgE in children with asthma and other chronic respiratory symptoms.

Authors:  Katir K Patel; Erica Anderson; Paul S Salva; Wilmore C Webley
Journal:  Respir Res       Date:  2012-04-18

8.  Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.

Authors:  Kelly L Asquith; Jay C Horvat; Gerard E Kaiko; Alison J Carey; Kenneth W Beagley; Philip M Hansbro; Paul S Foster
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

9.  TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life.

Authors:  Emma L Beckett; Simon Phipps; Malcolm R Starkey; Jay C Horvat; Kenneth W Beagley; Paul S Foster; Philip M Hansbro
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

10.  Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

Authors:  David L Hahn; Allison Schure; Katir Patel; Tawanna Childs; Eduard Drizik; Wilmore Webley
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.